"It has come to knowledge of NPPA that several medical devices are available in the market and also being used in health care facilities where no MRP is printed on the package by manufacturers/importers," National Pharmaceutical Pricing Authority (NPPA) said in a notification.

This is a blatant violation of law of the land, it added.

The government has notified 22 medical devices as drugs under the Drugs and Cosmetics Act, 1940 and the Drugs and Cosmetic Rules, 1945, it said.

In a tweet, NPPA said: "22 medical devices notified as 'drugs' must print MRP on the packs under DPCO, 2013; State Govts/State Drug Controllers requested to enforce law."

These devices are non-scheduled formulations and their sales are governed by the provisions of DPCO 2013, the notification said.

The prices of non-scheduled formulations are monitored by the government. Manufacturers are not allowed to increase the price of these more than 10 per cent per annum, NPPA said.

Condoms, intra uterine device containing copper and coronary stents have been included in the Schedule-I of DPCO, 2013, and are under price control, it added.

Subscribe ETHealthworld Newsletter

Lyrica, known generically as pregabalin, was originally developed for epilepsy but further research showed it could also help patients suffering from neuropathic pain, which soon became its main market.

With this acquisition, Nephroplus will further strengthen its servicing capacity as the dominant dialysis centre network and will have a presence in 18 states of India with 176 centers across 97 cities.